Sue Washer | President and CEO |
Matthew Feinsod | CMO |
Bill Sullivan | CFO |
Matthew Luchini | BMO Capital Markets |
Mara Goldstein | Cantor Fitzgerald |
Good day and welcome to the AGTC Financial Results Conference Call for the First Quarter of Fiscal Year 2018. Today's call is being recorded.
Before we get started, I'd like to remind everyone that during this conference call AGTC may make forward-looking statements, including statements about the Company’s financial results, its future business strategies and operations, and product development and regulatory progress. Actual results could differ materially from those discussed in the forward-looking statements due to a number of important factors including uncertainty inherent in the clinical development and regulatory process and other risks described in the Risk Factors section of AGTC’s Annual Report on Form 10-K for the fiscal year ended June 30, 2017.
For introductions and opening remarks, I’d like to turn the call over to Sue Washer, Chief Executive Officer of AGTC.